Does Chia Tai Tianqing produce avatrombopag?

As a leading domestic innovative pharmaceutical company, Chia Tai Tianqing Pharmaceutical Group continues to promote research and development progress in the field of blood diseases and has successfully developed avatrombopag (Avatrombopag) generic drug. This drug is a type of thrombopoietin receptor agonist (TPO-RA) and is widely used in the treatment of thrombocytopenia. Through continuous technical research, Zhengda Tianqing took the lead in completing the research and development of this generic drug and promoted its approval for marketing.

2023 In December 2023, Nanjing Zhengda Tianqing Pharmaceutical’s avatrombopag maleate tablets were approved by the National Medical Products Administration (NMPA) for official marketing, and were deemed to have passed the consistency evaluation, becoming one of the first domestic generic companies of this variety. This achievement marks that the quality and efficacy of domestically produced avatrombopag have reached the same level as the original drug, which is of great significance in promoting domestic substitution of imported drugs.

Avatrombopag maleate is indicated for the treatment of adult patients with thrombocytopenia associated with chronic liver disease who are scheduled to undergo elective diagnostic procedures or surgery. Such patients often face a higher risk of bleeding due to insufficient platelet count before undergoing surgery or invasive procedures. This drug can effectively increase platelet levels and help patients complete treatment safely and successfully.

In addition to avatrombopag, Chia Tai Tianqing also produces eltrombopag ethanolamine tablets (trade name: Taiprosin), which is used to treat patients with chronic immune thrombocytopenia (ITP). With the launch of multiple TPO-RA drugs, Chia Tai Tianqing has not only broadened its product line, but also greatly enriched patients' treatment options, improved drug accessibility, and helped more thrombocytopenia patients obtain high-quality treatment options.

Reference materials:https://go.drugbank.com/drugs/DB11995